Mari Ángeles performed her PhD studies at the University of Valencia (Spain). Then, she embarked in several postdoctoral studies at University of Cambridge (UK), Institute of Medical Biology A-Star (Singapore), CNRS institutions–CRBM in Montpellier, CRCM-Institute Paoli-Calmettes and Institut Fresnel in Marseille (France) and Brandeis University (MA, USA). She became team leader at Teesside University, UK in 2020. Her goal is to understand cytoskeleton mechanisms in collective migration, cancer invasion and cell division. Her ultimate goal is to find novel biomarkers for early detection and assist the design for novel compounds suitable for personalized therapies.

Mari loves to play music, run and bike with family and friends.